Cancer Family
Connective and Soft Tissue Neoplasm
CI-CAN-00000010Explore in graph →
Non-malignant849 active trials17 approved drugs339 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000010Explore in graph →
Clinical trials
3,878 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00513981 | High-Dose Methotrexate in Treating Young Patients With Solid Tumors | completed | Phase 1 | 36 | Children's Cancer and Leukaemia GroupOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00003667 | Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00002515 | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00023725 | Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00023738 | Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00052390 | Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00104949 | Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma | completed | Phase 2 | 40 | SWOG Cancer Research NetworkNETWORK | 0 | Jun 24, 2013 | clinicaltrials |
| NCT00003776 | Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005033 | Trastuzumab in Treating Patients With Recurrent Osteosarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006005 | Thalidomide in Treating Patients With Gynecologic Sarcomas | completed | Phase 2 | — | New York University Cancer InstituteOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00002466 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019240 | Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00295984 | Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma | completed | Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00005625 | Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005628 | Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020449 | Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020527 | Caspofungin Acetate in Treating Children With Fever and Neutropenia | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00031915 | Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00066599 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01459757 | Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib | completed | — | 322 | PfizerINDUSTRY | 16 | Jun 19, 2013 | clinicaltrials |
| NCT00003958 | Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma | completed | Phase 3 | 702 | Children's Oncology GroupNETWORK | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00004078 | Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 2 | 181 | Children's Oncology GroupNETWORK | 1 | Jun 14, 2013 | clinicaltrials |
| NCT00005643 | Chemotherapy in Treating Patients With Sarcoma of the Uterus | completed | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00570635 | A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib | completed | Phase 2 | 16 | ExelixisINDUSTRY | 1 | Jun 7, 2013 | clinicaltrials |
| NCT00027716 | Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00064142 | Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00077454 | Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 95 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00101270 | Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00107432 | Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00064324 | Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma | completed | Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00087074 | CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00093821 | Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors | completed | Phase 1 | 70 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00040911 | Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma | completed | N/A | 17 | Children's Oncology GroupNETWORK | 1 | May 31, 2013 | clinicaltrials |
| NCT00558272 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | completed | Phase 2 | 139 | AstraZenecaINDUSTRY | 8 | May 27, 2013 | clinicaltrials |
| NCT00441155 | Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 3 | May 13, 2013 | clinicaltrials |
| NCT01851928 | Validation of a Nutrition Screening Tool | completed | — | 128 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 2 | May 3, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT01261429 | Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | completed | Phase 2 | 50 | Centre Leon BerardOTHER | 5 | Apr 16, 2013 | clinicaltrials |
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01830153 | RAD001 in Advanced Sarcoma | completed | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00864032 | Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall | completed | Phase 1 / Phase 2 | 8 | University of California, DavisOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00842452 | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 26 | Steven Waggoner, MDOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00889057 | Sorafenib in Relapsed High Grade Osteosarcoma | completed | Phase 2 | 35 | Italian Sarcoma GroupNETWORK | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00003408 | Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer | completed | Phase 2 | 40 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00410488 | Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) | completed | N/A | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00098579 | Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01811524 | The Etiology and Progression of Brain Tumors | completed | — | 2,000 | Tampere University HospitalOTHER | 0 | Mar 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 26, 2013source: clinicaltrials